Unraveling the role of gut microbiota and immune cells in thyroid cancer and tumor drug resistance
Abstract The gut microbiota (GM) and immune cells (IC) are increasingly recognized as key players in cancer development and progression. This study aimed to explore the potential mediating role of IC in the causal relationship between GM and thyroid cancer (TC) using Mendelian randomization (MR) ana...
Saved in:
| Main Authors: | Jiaqin Deng, Yihua Gu, Ming Yu, Yeqian Lai, Lihong Qiu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2024-11-01
|
| Series: | Discover Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s12672-024-01585-x |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Exploring the role of EBV ZEBRA antibody levels in papillary thyroid cancer risk and drug resistance
by: Jiaqin Deng, et al.
Published: (2025-04-01) -
Causal associations between circulating protein ratios and drug resistance in papillary thyroid cancer: a Mendelian randomization study
by: Jiaqin Deng, et al.
Published: (2025-01-01) -
Gene prediction of immune cells association between gut microbiota and colorectal cancer: a Mendelian randomization study
by: Yan Zhong, et al.
Published: (2025-01-01) -
Potential causal association between gut microbiota, inflammatory cytokines, and acute pancreatitis: A Mendelian randomization study
by: Xiaofeng Wang, et al.
Published: (2025-04-01) -
Identification of 1,400 metabolites as mediators of obesity in 473 gut microbiota taxa: a mediation Mendelian randomization study
by: Xiaomin Li, et al.
Published: (2025-06-01)